Image

The Safety, Tolerability and Efficacy of NouvNeu001 for Parkinson's Disease

Testing NouvNeu001 for safety and effectiveness in Parkinson's Disease.

Recruiting
50-75 years
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study tests the safety and effectiveness of NouvNeu001, a special cell injection, for people with Parkinson's disease. The trial uses a technique called stereotactic neurosurgery to place the cells in specific brain areas (putamen/striatum). Participants will need to take drugs called immunosuppressants for about 24 to 36 weeks to prevent their body from rejecting the cells.

Eligibility: People aged 50-75 with Parkinson's diagnosis from 4 to 20 years ago can join if they are fit for surgery and have certain test scores. They should not have other major health issues or have had certain previous surgeries.

  • Duration: The study lasts at least 24 weeks.
  • Medical Visits: You will need to go for regular check-ups and imaging tests like MRI and PET scans.
  • Risks: Possible risks include surgery complications and side effects from immunosuppressants.

Consider if the time commitment, medical visits, and potential risks are suitable for you before participating. For more information, discuss with your doctor or the study team.

Print
Study details
    Parkinson Disease

NCT06167681

iRegene Therapeutics Co., Ltd.

17 April 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.